Titan Pharmaceuticals
TTNP
TTNP
22 hedge funds and large institutions have $1.76M invested in Titan Pharmaceuticals in 2018 Q1 according to their latest regulatory filings, with 3 funds opening new positions, 4 increasing their positions, 4 reducing their positions, and 2 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
22
Holders Change
+1
Holders Change %
+4.76%
% of All Funds
0.5%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
3
Increased
4
Reduced
4
Closed
2
Calls
$53K
Puts
–
Net Calls
+$53K
Net Calls Change
-$13K
Top Buyers
1 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$68.6K |
2 |
Renaissance Technologies
New York
|
+$53K |
3 |
Citadel Advisors
Miami,
Florida
|
+$39K |
4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$11.3K |
5 |
Bank of New York Mellon
New York
|
+$3.4K |
Top Sellers
1 |
Millennium Management
New York
|
-$38K |
2 |
WS
Wedbush Securities
Los Angeles,
California
|
-$18K |
3 |
TSS
Two Sigma Securities
New York
|
-$16K |
4 |
Morgan Stanley
New York
|
-$4K |
5 |
BlackRock
New York
|
-$3.77K |